Literature DB >> 28682828

Criteria for Intensive Care admission and monitoring after elective craniotomy.

Rafael Badenes1, Lara Prisco, Armando Maruenda, Fabio S Taccone.   

Abstract

PURPOSE OF REVIEW: The current article revises the recent evidence on ICU admission criteria and postoperative neuromonitoring for patients undergoing elective craniotomy. RECENT
FINDINGS: Only a small proportion of elective postoperative neurosurgical patients require specific medical interventions and invasive monitoring. Among these, patients undergoing elective craniotomy are frequently admitted to neuro-ICU, specialist postanaesthesia care units or intermediate-level care unit in the postoperative period.Craniotomy patients have a high risk of neurological complications in the immediate postoperative period and might require advanced neuromonitoring, especially if sedation is continued in the ICU.Furthermore, the concept of enhanced recovery after surgery with the goal of improving functional capacity after surgery and decreasing morbidity has expanded to encompass neurosurgery.Postoperative clinical examination and neurological scores, bispectral index and simplified electroencephalography, and morning discharge huddles are the most used strategies in this context.
SUMMARY: After elective craniotomy, ICU admission should be warranted to patients who show new neurological deficits, especially when these include reduced consciousness or deficits of the lower cranial nerves, or have surgical indication for delayed extubation. Currently, evidence does not allow defining standardized protocol to guide ICU admission and postoperative neuromonitoring.

Entities:  

Mesh:

Year:  2017        PMID: 28682828     DOI: 10.1097/ACO.0000000000000503

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  2 in total

1.  Implementation of the "No ICU - Unless" approach in postoperative neurosurgical management in times of COVID-19.

Authors:  Lina-Elisabeth Qasem; Ali Al-Hilou; Kai Zacharowski; Moritz Funke; Ulrich Strouhal; Sarah C Reitz; Daniel Jussen; Marie Thérèse Forster; Juergen Konczalla; Vincent Matthias Prinz; Kristin Lucia; Marcus Czabanka
Journal:  Neurosurg Rev       Date:  2022-09-08       Impact factor: 2.800

2.  Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.

Authors:  Regin Jay Mallari; Michael B Avery; Alex Corlin; Amalia Eisenberg; Terese C Hammond; Neil A Martin; Garni Barkhoudarian; Daniel F Kelly
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.